| Endpoint | Cohort A | Cohort B | p value |
| Median OS | 35 months | NR | p = 0.481 |
| Alive at 24 months | 64.8% | 75.0% |
|
| Alive at 36 months | 48.6% | 75.0% |
|
| Median PFS | 31 months | 34 months | p = 0.368 |
| no disease progression at 24 months | 64.3% | 91.7% |
|
| no disease progression at 36 months | 42.9% | 22.9% |
|